Open original FDA record ↗Recall record
- FDA identifier
- Z-1798-2013
- Company in FDA record
- Becton Dickinson & Co.
- FDA classification date
- Jul 24, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Microbiological identification media may exhibit reduced levels of Vancomycin.
Source facts
- Action
- The firm, BD Diagnostic Systems, sent an "URGENT PRODUCT RECALL" letter dated June 2013 to Distributors by fax, US customers via letters by UPS and OUS BD sites via email and teleconference. The letter described the product, problem and actions to be taken. All customers were instructed to discontinue use of the listed product; discard any remaining packages, and complete and return the attached form, whether or not you have any inventory remaining, via Fax to: Attention: Regulatory Compliance, 410-316-4258. BD will issue replacements for the discarded material. It is not necessary to contact BD by telephone to receive replacements. If you have any questions, call 410-316-4000.
- Initiated
- 2013-06-06
- Root cause
- Nonconforming Material/Component
- Terminated
- 2013-09-03
- Distribution
- Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.
- Recall number
- Z-1798-2013
- Recall status
- Terminated
- CDRH record ID
- 119714
- FDA classified
- 2013-07-24
- Recall event number
- 65614